Functions of antibodies
An antibody does no harm by itself. Its arms bind and block; once they have bound, its stem calls in complement, phagocytes and killer cells. The stem also works with no antigen bound: it arms mast cells with IgE, and carries antibody into secretions and across the placenta.
- 12 min read
- 6 questions
- Checked 29 Oct 2026
Contents11 sections
At a glance
- An antibody's arms (Fab) bind the antigen; its stem (Fc) binds complement or the Fc receptors of cells, which do the killing. Free IgG and IgM set off little, so the killing comes where antigen has been found. Some receptors hold or carry antibody with no antigen bound: FcεRI arms mast cells with IgE, and pIgR and FcRn carry antibody across cells.
- Alone, antibody neutralises: it covers what a toxin, virus or bacterium needs to attach or enter. This needs only the arms. With many binding sites it agglutinates particles into clumps; IgM and secretory IgA do this best.
- Complement: C1q binds several Fc held close together, on an IgM bound to a surface or a cluster of bound IgG, and starts the classical pathway. C3b coats the target, C5a calls in neutrophils, and the membrane attack complex lyses some bacteria.
- Fc receptors: Fcγ receptors on macrophages and neutrophils engulf IgG-coated microbes (opsonisation); CD16 on NK cells kills IgG-coated infected and tumour cells (ADCC); FcεRI holds IgE on mast cells, and an allergen that links two IgE releases histamine within minutes.
- Transport: the polymeric immunoglobulin receptor carries dimeric IgA through epithelial cells into secretions; FcRn carries IgG across the placenta and rescues it from breakdown, so most IgG lasts about three weeks in the blood.
- Each class has its jobs: IgM agglutinates and activates complement, IgG does almost everything and crosses the placenta, IgA guards the mucosae, and IgE arms mast cells against worms and in allergy.
Binding first, then acting
Antibodies do no damage themselves. They block, clump and mark, and the destruction is done by others: complement, phagocytes, natural killer cells, mast cells and eosinophils. The two ends of the molecule share the work. The Fab arms bind the epitope; the Fc stem, which differs from class to class, binds the molecules and cells that act.
An antibody bound to its antigen forms an immune complex. Free antibody circulates without setting off complement, and most Fc receptors bind single antibody molecules too weakly to hold them. Many Fc held close together, on a coated microbe or in a complex, bind strongly. So the help an antibody calls arrives where it has found its antigen.
Neutralisation and agglutination need only the arms; complement and the Fc receptors need the Fc. Which functions an antibody has depends on its class and, for IgG, its subclass: as a rule IgG1 and IgG3 bind complement and Fc receptors best, IgG2 and IgG4 less well.
Step 1 of 3Neutralisation. Antibodies on the virus's spikes keep it from binding the receptor it enters by, so it cannot infect a cell. Antibody against a toxin works the same way.
Point at a name or a part to light it.
An antibody's arms bind; its stem decides what follows. Bound to a virus or a toxin, the arms alone can stop it. Bound to a bacterium, the stems are handles for phagocytes' Fc receptors and, in clusters, for C1q, which starts complement.
Simplified: not to scale, and each scene at its own: a bacterium is many times wider than the antibodies on it; the virus drawn small and simple, a dozen spikes; a real one carries many more; the Fcγ receptors drawn as one kind, a ball on a stalk; there are several, with different jobs; IgM side on, three of its five units in view, the others behind; IgM drawn with IgG's thin hinge; in its place it has a whole domain; C1r, C1s and the steps between C1 and C3 left out; one membrane stands for the bacterium's envelope, which in a Gram-negative bacterium has two.
7 sources
- Kumar and Clark's Clinical Medicine, 10th edition. Elsevier, 2021. Chapter 3, Immunity: complement, opsonisation (Fig. 3.3, Box 3.4) and immunoglobulins.
- Silverthorn DU. Human Physiology, An Integrated Approach, 8th edition. Pearson, 2019. Chapter 24, complement (Fig. 24.6) and antibody functions.
- Forthal DN. Functions of antibodies. Microbiol Spectr. 2014;2(4):AID-0019-2014.
- Gillis C, Gouel-Chéron A, Jönsson F, Bruhns P. Contribution of human FcγRs to disease with evidence from human polymorphisms and transgenic animal studies. Front Immunol. 2014;5:254.
- Heesterbeek DAC, Bardoel BW, Parsons ES, et al. Bacterial killing by complement requires membrane attack complex formation via surface-bound C5 convertases. EMBO J. 2019;38(4):e99852.
- V'kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155–170.
- Keyt BA, Baliga R, Sinclair AM, Carroll SF, Peterson MS. Structure, function, and therapeutic use of IgM antibodies. Antibodies. 2020;9(4):53.
Neutralisation
An antibody that covers the molecules a microbe or toxin needs stops it without help. This is neutralisation.
- Toxins. Antibody bound to a bacterial toxin keeps it off our cells. The diphtheria vaccine is an inactivated toxin: it raises antibody that neutralises the real toxin when the bacteria make it.
- Viruses. Antibody against a virus's attachment protein keeps it from its receptor, as antibody against the gp120 of HIV keeps it from CD4. Other antibodies stop the viral and cell membranes from fusing, or the virus from uncoating once inside. Usually several antibodies must bind one virion to neutralise it.
- Bacteria and other microbes. Antibody against adhesins, often on the bacteria's pili and fimbriae, keeps them from sticking to epithelium, the first step of most infections. Secretory IgA in breast milk does this for gut bacteria in the infant.
A Fab fragment can be enough. Neutralisation stops an infection before it starts, and like antibody in general it works best outside cells, on toxins and on viruses that have not yet entered a cell.
Agglutination
An IgG has two binding sites, a secretory IgA four and an IgM pentamer ten. Binding epitopes on different particles links them, so bacteria, viruses or red cells are drawn into clumps: agglutination. Clumped microbes reach fewer cells, are caught in mucus and are taken up by phagocytes more easily. IgM and the polymeric IgA, with their many sites, agglutinate best. On the mucosae secretory IgA holds microbes in the mucus, to be swept away before they reach the epithelium, a defence called immune exclusion.
Complement
Antibody bound to a surface starts the classical pathway of complement. Its first component, C1q, has six heads and holds fast only where several Fc stand close together.
- IgM in the blood is a flat disc. When it binds a surface its arms bend down onto it, like a staple, and its Fc are presented together. This is why IgM activates complement far better than IgG.
- IgG must bind close together: bound molecules gather through their Fc into rings of six, a platform for C1q. IgG3 and IgG1 do this best. IgG2 does it only where antigen is dense, as on bacterial polysaccharide, and IgG4 hardly binds C1q.
- IgA, IgE and IgD do not activate the classical pathway.
Once C1 is active, the cascade runs as in the innate response, and its products serve the antibody. C3b coats the target, a second handle for phagocytes beside the Fc. C5a above all draws in neutrophils, and C3a and C5a both make vessels leaky. The membrane attack complex (C5b to C9) punches holes in the outer membrane of some bacteria, notably Neisseria. Complement also helps clear immune complexes from the blood: C3b on a complex binds complement receptor 1 on red cells, which hold it until tissue macrophages take it off.
Fc receptors
Most cells that act for antibodies hold them by their Fc. Each class has its own receptors, and each receptor its own cells.
| Receptor | Binds | Main cells | What it does |
|---|---|---|---|
| FcγRI (CD64) | IgG, even single molecules | monocytes, macrophages, dendritic cells; neutrophils when inflamed | phagocytosis |
| FcγRIIa (CD32a) | IgG in complexes | all myeloid cells: monocytes, macrophages, neutrophils, eosinophils, mast cells | phagocytosis, activation |
| FcγRIIb (CD32b) | IgG in complexes | B cells, basophils, some macrophages | inhibits the cell |
| FcγRIIIa (CD16a) | IgG in complexes | NK cells, monocytes, macrophages | ADCC |
| FcγRIIIb (CD16b) | IgG in complexes | neutrophils | with FcγRIIa, gathers neutrophils where immune complexes lie |
| FcεRI | IgE, even single molecules | mast cells, basophils | degranulation |
| FcαRI (CD89) | IgA | neutrophils, monocytes, macrophages | phagocytosis, activation |
| Polymeric Ig receptor | dimeric IgA, pentameric IgM | mucosal epithelial cells | carries them into secretions |
| FcRn | IgG and albumin, at acid pH | placenta, endothelium, epithelia, blood cells | carries IgG across cells; saves it from breakdown |
High-affinity receptors (FcγRI, FcεRI) can hold a single free antibody; the other Fcγ receptors and FcαRI hold well only antibody gathered in complexes or on a surface. The transport receptors, pIgR and FcRn, carry free antibody. Most Fc receptors switch the cell on. FcγRIIb switches it off: on B cells, immune complexes bound to it hold back their activation.
Opsonisation and phagocytosis
To opsonise is to coat a particle so a phagocyte takes it more readily. Many bacteria, above all those with a polysaccharide capsule, slip past phagocytes on their own. Coated with IgG, they are gripped by the Fcγ receptors of macrophages and neutrophils; coated also with C3b, they are gripped by complement receptors as well. The phagocyte wraps the microbe, closes it into a phagosome and kills it there.
Opsonisation is why antibody and complement matter most against capsulated bacteria such as pneumococcus and Haemophilus influenzae, and why the spleen, full of macrophages that take coated bacteria from the blood, matters too. Against meningococcus, another capsulated bacterium, killing by complement matters more than phagocytosis.
Killing by NK cells: ADCC
Natural killer cells carry CD16 (FcγRIIIa). When IgG coats a cell, a virus-infected cell showing viral proteins on its surface or a tumour cell, CD16 binds the Fc and the NK cell releases perforin, which opens pores, and granzymes, which drive the target into apoptosis. This is antibody-dependent cellular cytotoxicity (ADCC). The antibody brings the specificity, the NK cell the killing. Antibodies used against tumours, such as rituximab against CD20 on B lymphoma cells, work partly this way.
Eosinophils, macrophages and neutrophils can kill antibody-coated targets too. Worms are far too large to swallow: coated with IgE or IgG, the larvae of Schistosoma and other helminths are attacked by eosinophils, which release their toxic granule proteins onto the worm's surface.
IgE, mast cells and eosinophils
IgE is the scarcest antibody in the blood, and it does its work bound to cells. Mast cells in the tissues and basophils in the blood bind it by its Fc to FcεRI, which holds IgE so tightly that it stays on the cell with no antigen bound. The cell is then armed with receptors made by B cells, for whatever antigens they recognise.
When an antigen with two or more epitopes binds two neighbouring IgE, it draws their receptors together. Cross-linking, not binding alone, is the signal. Within minutes the mast cell releases what its granules hold, histamine, proteases such as tryptase, and heparin, then makes prostaglandin D2 and leukotrienes. Vessels dilate and leak, and the smooth muscle of the airways and gut contracts. Against worms this is part of the defence. Against pollen, food or venom it is allergy, immediate (type I) hypersensitivity, from hay fever and urticaria to anaphylaxis. A late phase follows hours later, as eosinophils and T cells arrive.
Step 1 of 2NK cells kill coated cells (ADCC). IgG binds viral proteins on an infected cell. CD16 on an NK cell grips the stems, and the NK cell empties perforin and granzymes onto the cell, which dies.
Point at a name or a part to light it.
Fc receptors let a cell borrow an antibody's aim. An NK cell can kill an infected cell that IgG has coated; a mast cell, already wearing IgE, empties its granules within minutes of an allergen joining two of them.
Simplified: not to scale, and each scene at its own; the gap between the two cells drawn wide, to show the antibodies in it; granzymes drawn as loose dots; they leave the granule bound to other proteins; only the IgE round the top of the mast cell drawn; it wears them all over; IgE drawn with IgG's thin hinge; in its place it has a whole domain; granule contents drawn as a pink core; each holds many mediators besides histamine; eosinophils, basophils and macrophages, which also kill or release through Fc receptors, left out.
6 sources
- Kumar and Clark's Clinical Medicine, 10th edition. Elsevier, 2021. Chapter 3, Immunity: natural killer cells.
- Silverthorn DU. Human Physiology, An Integrated Approach, 8th edition. Pearson, 2019. Chapter 24, antibody functions and cytotoxic cells.
- V'kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155–170.
- Gillis C, Gouel-Chéron A, Jönsson F, Bruhns P. Contribution of human FcγRs to disease with evidence from human polymorphisms and transgenic animal studies. Front Immunol. 2014;5:254.
- Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18(5):693–704.
- Keyt BA, Baliga R, Sinclair AM, Carroll SF, Peterson MS. Structure, function, and therapeutic use of IgM antibodies. Antibodies. 2020;9(4):53.
Secretory IgA at the mucosae
More IgA is made than all the other classes together, much of it by plasma cells under the mucosae of the gut, airways and glands. They secrete it as a dimer, two units joined by the J chain, into the lamina propria. To reach the lumen it has to cross the epithelium, which it cannot do alone:
- 1
Binding
The polymeric immunoglobulin receptor (pIgR) on the basolateral surface of the epithelial cell binds the dimer where its J chain joins the stems, gripping both; IgA without a J chain is not carried. The receptor's outer part spreads across one face of the dimer.
- 2
Transcytosis
The cell takes receptor and IgA into a vesicle and carries it across to the apical surface.
- 3
Release
At the apical surface the receptor is cut below its outer part, which stays bound to the IgA as the secretory component, and the complex, secretory IgA, is released into the mucus.
Step 1 of 3Binding. A plasma cell secretes dimeric IgA. pIgR on the base of an epithelial cell binds a dimer, its outer part gripping the J chain and the stems beside it.
Point at a name or a part to light it.
The epithelium carries IgA across itself. Plasma cells under it make dimers; pIgR takes them from the base to the top, and its cut outer part stays on as the secretory component, which helps the IgA last in the gut.
Simplified: not to scale: the antibodies are drawn many times larger against the cells and bacteria; pIgR drawn as a stalk of three beads, its five outer domains as ovals once they lie across a dimer; a waiting receptor's outer domains, folded together, are not drawn; the dimer drawn flat and straight; its two units are bent and tilted against each other; one dimer drawn at each stage of the way, side by side, though in the gut many cross each cell at once; the basement membrane under the epithelium left out; the mucus drawn as one even layer.
3 sources
- de Sousa-Pereira P, Woof JM. IgA: structure, function, and developability. Antibodies. 2019;8(4):57.
- Kumar Bharathkar S, Parker BW, Malyutin AG, et al. The structures of secretory and dimeric immunoglobulin A. eLife. 2020;9:e56098.
- Keyt BA, Baliga R, Sinclair AM, Carroll SF, Peterson MS. Structure, function, and therapeutic use of IgM antibodies. Antibodies. 2020;9(4):53.
In the lumen secretory IgA neutralises toxins and viruses, keeps bacteria from the epithelium and holds them in the mucus. It does all this without setting off complement, so it protects without inflaming the gut wall it lies on. It works even on its way through: IgA meeting a virus inside the epithelial cell can stop it there. Secretory IgA is also the main antibody of breast milk, and in a breast-fed baby's gut it keeps bacteria from the epithelium.
IgG across the placenta, and FcRn
The fetus makes little antibody of its own. IgG is the only class that crosses the placenta in useful amounts, carried by the neonatal Fc receptor (FcRn) of the syncytiotrophoblast. Transfer starts at about 13 weeks and rises steadily, and most of the baby's IgG arrives in the last four weeks. At term the baby's IgG is usually higher than its mother's, by a fifth to nearly a third. IgG1 crosses best, IgG2 least. A baby born early has less.
This maternal IgG protects the newborn against the infections the mother is immune to for the first months, until it is broken down; the baby's own antibody production rises meanwhile. The same transfer carries harmful maternal IgG: the antibodies of a mother with myasthenia gravis can cause transient weakness in her newborn.
FcRn keeps working for life. Endothelial cells take in plasma constantly in small vesicles, and the proteins in them are bound for the lysosomes. In the acid of the endosome, FcRn binds IgG and albumin, carries them back to the cell surface and lets them go at the neutral pH of the blood. This rescue is why most IgG, and albumin, last about three weeks in the blood, against a week at most for IgA and most other plasma proteins. The rescue can be saturated: a large dose of IgG speeds the loss of the body's own.
- when IgG transfer across the placenta begins
- 13weeks of pregnancy
- the half-life of IgG, kept long by FcRn
- 21days
- on an IgM pentamer, the best agglutinator
- 10binding sites
Which class does what
| IgG | IgM | IgA | IgE | IgD | |
|---|---|---|---|---|---|
| Neutralises | ++ | + | ++ (secretions) | ||
| Agglutinates | + | +++ | ++ (secretory) | ||
| Classical complement | ++ (IgG3, IgG1) | +++ | |||
| Opsonises (Fc receptors) | ++ | + (FcαRI) | |||
| ADCC by NK cells | ++ | ||||
| Arms mast cells and basophils | ++ | ||||
| Crosses the placenta | ++ | ||||
| Carried into secretions | + | ++ | |||
| Main place | blood and tissues | blood, first response | mucosae, milk | on mast cells | on naive B cells |
A first response to an antigen is slow, one to two weeks, and its first antibodies are IgM. Its B cells then switch, guided by T cells, to IgG, IgA or IgE, keeping the same variable region. A second response is faster and larger, mostly IgG of higher affinity, which is why the second dose of a vaccine, and the second meeting with a microbe, work better than the first.
Check yourselfAnswer, then say how sure you were: a lucky guess still counts as a weak point.
1A Fab fragment against a virus's attachment protein still protects cells in culture. Which function has it kept?
2Why does IgM activate the classical complement pathway far better than IgG?
3Which receptor lets a natural killer cell kill a target cell coated with IgG?
4A mast cell carries IgE against birch pollen on its FcεRI. What makes it degranulate?
5A boy with X-linked agammaglobulinaemia, who has no B cells, stays well for his first months and then has repeated bacterial infections. Why the delay?
6How does dimeric IgA made in the lamina propria reach the gut lumen?